Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil

International Journal of Clinical Practice

Volumn 63, Issue 2, 2009, Pages 299-302

  Cin, M Ozduman ^a   Gursoy, A ^a   Morris, Y ^a   Aydintug, O Tiryaki ^a   Kamel, N ^a   Gullu, S ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; ANTITHYROID AGENT;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TOXIC GOITER; CROSS-SECTIONAL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; PROPYLTHIOURACIL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58449107358     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01250.x     Document Type: Article

References (20)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997 337 : 1512 23.
2. Reumaux D, Duthilleul P, Roos D. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum Immunol 2004 65 : 1 12.
3. Sable-Fourtassou R, Cohen P, Mahr A et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005 143 : 632 8.
4. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998 41 : 1521 37.
5. Sinico RA, Radice A, Corace C et al. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis. Ann N Y Acad Sci 2005 1050 : 185 92.
6. Bonaci-Nikolic B, Nikolic MM, Andrejevic S et al. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005 7 : 1072 81.
7. Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992 102 : 1595 6.
8. Dolman KM, Gans RO, Vervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993 342 : 651 2.
9. Vogt BA, Kim Y, Jennette JC et al. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994 124 : 986 8.
10. Tanemoto M, Miyakawa H, Hanai J et al. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995 26 : 774 80.
11. Harper L, Chin L, Daykin J et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol 2004 60 : 671 5.
12. Afeltra A, Paggi A, De Rosa FG et al. Antineutrophil cytoplasmic antibodies in autoimmune thyroid disorders. Endocr Res 1998 24 : 185 94.
13. Guma M, Salinas I, Reverter JL et al. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab 2003 88 : 2141 6.
14. Savige J, Gillis D, Benson E et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999 111 : 507 13.
15. Wada N, Mukai M, Kohno M et al. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr J 2002 49 : 329 34.
16. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999 84 : 13 6.
17. Sera N, Ashizawa K, Ando T et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000 10 : 595 9.
18. Lam DC, Lindsay RH. Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol 1979 28 : 2289 96.
19. Lee E, Hirouchi M, Hosokawa M et al. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol 1988 37 : 2151 3.
20. Otsuka S, Kinebuchi A, Tabata H et al. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy. Br J Dermatol 2000 142 : 828 30.